Harborside


Entourage Health Corp.

CVE: ENTG


Canadian symbol: ENTG.V
US symbol: ETRGF

Currency in CAD

Valuation Measures4

Market Cap (intraday) 10.74M
Enterprise Value 112.86M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.24
Price/Book (mrq)2.69
Enterprise Value/Revenue 2.59
Enterprise Value/EBITDA -1.99

Trading Information

Stock Price History

Beta (5Y Monthly) 1.33
52-Week Change 3-82.50%
S&P500 52-Week Change 3-16.88%
52 Week High 30.2200
52 Week Low 30.0300
50-Day Moving Average 30.0490
200-Day Moving Average 30.0703

Share Statistics

Avg Vol (3 month) 392.73k
Avg Vol (10 day) 3103.42k
Shares Outstanding 5303.98M
Implied Shares Outstanding 6N/A
Float 8306.11M
% Held by Insiders 120.04%
% Held by Institutions 10.00%
Shares Short (Sept 14, 2022) 43.06k
Short Ratio (Sept 14, 2022) 40.02
Short % of Float (Sept 14, 2022) 4N/A
Short % of Shares Outstanding (Sept 14, 2022) 40.00%
Shares Short (prior month Aug 14, 2022) 424.23k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin -183.36%
Operating Margin (ttm)-98.46%

Management Effectiveness

Return on Assets (ttm)-17.89%
Return on Equity (ttm)-205.66%

Income Statement

Revenue (ttm)43.5M
Revenue Per Share (ttm)0.15
Quarterly Revenue Growth (yoy)-8.60%
Gross Profit (ttm)-11.71M
EBITDA -34.6M
Net Income Avi to Common (ttm)-79.77M
Diluted EPS (ttm)-0.2970
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.15M
Total Cash Per Share (mrq)0.05
Total Debt (mrq)116.28M
Total Debt/Equity (mrq)2,914.72
Current Ratio (mrq)3.60
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-28.18M
Levered Free Cash Flow (ttm)-19.74M

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
ENTG.V
Entourage Health
1 week ago
ENTG.V
Entourage Health
3 weeks ago
ENTG.V
Entourage Health
1 month ago
ENTG.V
Entourage Health
2 months ago
ENTG.V
Entourage Health
2 months ago
ENTG.V
Entourage Health
3 months ago
ENTG.V
Entourage Health
3 months ago
ENTG.V
Entourage Health
3 months ago
ENTG.V
Entourage Health
3 months ago
ENTG.V
Entourage Health
3 months ago
ENTG.V
Entourage Health
4 months ago
ENTG.V
Entourage Health
4 months ago
ENTG.V
Entourage Health
4 months ago
ENTG.V
Entourage Health
4 months ago
ENTG.V
Entourage Health
6 months ago
ENTG.V
Entourage Health
6 months ago
ENTG.V
Entourage Health
7 months ago
ENTG.V
Entourage Health
7 months ago
ENTG.V
Entourage Health
7 months ago
ENTG.V
Entourage Health
8 months ago
ENTG.V
Entourage Health
9 months ago
ENTG.V
Entourage Health
9 months ago
ENTG.V
Entourage Health
9 months ago
ENTG.V
Entourage Health
9 months ago
ENTG.V
Entourage Health
10 months ago
ENTG.V
Entourage Health
10 months ago
ENTG.V
Entourage Health
10 months ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
1 year ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
2 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago
ENTG.V
Entourage Health
3 years ago

Currency in CAD
Earnings EstimateCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
No. of Analysts0000
Avg. Estimate0000
Low Estimate0000
High Estimate0000
Year Ago EPSN/AN/AN/AN/A
Revenue EstimateCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
No. of Analysts1221
Avg. Estimate12.19M5.86M29.43M42.27M
Low Estimate13.6M8.3M31.69M43.41M
High Estimate13.6M8.6M32.6M43.41M
Year Ago Sales6.65M7.98M20.82M29.43M
Sales Growth (year/est)83.10%-26.60%41.40%43.60%
Earnings HistoryInvalid DateInvalid DateInvalid DateInvalid Date
EPS Est.N/AN/AN/AN/A
EPS ActualN/AN/AN/AN/A
DifferenceN/AN/AN/AN/A
Surprise %N/AN/AN/AN/A
EPS TrendCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
Current Estimate0000
7 Days Ago-0.040-0.14-0.17
30 Days Ago-0.040-0.14-0.17
60 Days Ago-0.040-0.14-0.17
90 Days Ago-0.040-0.14-0.17
EPS RevisionsCurrent Qtr. (Mar 2020)Next Qtr. (Jun 2020)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesENTG.VIndustrySector(s)S&P 500
Current Qtr.N/AN/AN/AN/A
Next Qtr.N/AN/AN/AN/A
Current YearN/AN/AN/AN/A
Next YearN/AN/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
20.04%% of Shares Held by All Insider
0.00%% of Shares Held by Institutions
0.00%% of Float Held by Institutions
0Number of Institutions Holding Shares
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by Entourage Health Corp.


Entourage Health Appoints Seasoned Executive James Afara to Chief Operating Officer

Entourage Health Appoints Seasoned Executive James Afara to Chief Operating Officer

TORONTO, Sept. 16, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products is pleased to announce the appointment of James Afara as the Company’s Chief Operating Officer (COO). A results-driven leader with an exceptional trac... Read More...
Entourage Health Signs Four New Union Groups to its Starseed Medicinal Program

Entourage Health Signs Four New Union Groups to its Starseed Medicinal Program

TORONTO, Aug. 30, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, is pleased to announce its medical subsidiary Starseed Medicinal (“Starseed”) has added four new union groups to its full-service, proprietary medical... Read More...
Entourage Health Reports Second Quarter 2022 Financial Results

Entourage Health Reports Second Quarter 2022 Financial Results

TORONTO, Aug. 29, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, announced today its financial results for the three and six months ended June 30, 2022. The Company reported second quarter 2022 total revenue of $13.... Read More...
Entourage Health Announces Second Quarter 2022 Financial Results Call to be held on August 30, 2022

Entourage Health Announces Second Quarter 2022 Financial Results Call to be held on August 30, 2022

TORONTO, Aug. 11, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products announced today it will file its second quarter 2022 financial statements and management’s discussion and analysis after-market on Monday, August 29, 2... Read More...
Entourage Health Signs Exclusive Licensing Agreement with Irwin Naturals to Produce and Distribute its Cannabis Products in Canada

Entourage Health Signs Exclusive Licensing Agreement with Irwin Naturals to Produce and Distribute its Cannabis Products in Canada

Irwin-branded cannabis products will be first available to Starseed Medicinal patients in Q4 2022 Strategic nutraceuticals partnership follows recent release of recommendations for easing access to over-the-counter CBD-products in pharmacies TORONTO, Aug. 04, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage... Read More...
Entourage Health Provides Update on Credit Facilities' Maturity Dates and Amends Outstanding Unsecured Convertible Debentures

Entourage Health Provides Update on Credit Facilities’ Maturity Dates and Amends Outstanding Unsecured Convertible Debentures

TORONTO, July 29, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, confirmed today it has satisfied certain conditions in connection with the recent amendments to its existing senior secured credit facility entered in... Read More...
Entourage Expands Medical Offerings with Launch of New Services and Products

Entourage Expands Medical Offerings with Launch of New Services and Products

Starseed signs with HelloMD’s telehealth network to support high volume of patient consultations Debuts customized patient treatment plans which could support pain management and opioid-displacement TORONTO, July 26, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and... Read More...
Entourage Health Announces Amendments to its Credit Facilities to Improve Debt Position and Support Strategic Long-Term Growth

Entourage Health Announces Amendments to its Credit Facilities to Improve Debt Position and Support Strategic Long-Term Growth

TORONTO, July 04, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, is pleased to announce it has amended its existing senior secured credit facility entered into on March 29, 2019 (the “Senior Credit Facility”) betwee... Read More...
Entourage Health Announces $8.9 Million Upsize to Credit Facility and Implementation of Proposed Amendments to 8.5% Unsecured Convertible Debentures

Entourage Health Announces $8.9 Million Upsize to Credit Facility and Implementation of Proposed Amendments to 8.5% Unsecured Convertible Debentures

TORONTO, June 27, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, announced today it has amended and upsized its existing credit facility (the “Credit Facility”) with an affiliate of the LiUNA Pension Fund of Central... Read More...
Entourage Health Provides Update on Proposed Amendments to its 8.5% Unsecured Convertible Debentures

Entourage Health Provides Update on Proposed Amendments to its 8.5% Unsecured Convertible Debentures

TORONTO, June 21, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, is pleased to provide an update on the previously announced proposed amendments (the “Proposed Amendments”) to the trust indenture dated as of Septemb... Read More...
Entourage Health Announces Debentureholders Overwhelmingly Approve Proposed Amendments to 8.5% Unsecured Convertible Debentures

Entourage Health Announces Debentureholders Overwhelmingly Approve Proposed Amendments to 8.5% Unsecured Convertible Debentures

TORONTO, June 20, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, is pleased to announce that holders (the “Debentureholders”) of the Company’s 8.5% unsecured convertible debentures due September 25, 2022 (the “Deben... Read More...
Entourage Announces Results of 2022 Annual General Meeting of Shareholders

Entourage Announces Results of 2022 Annual General Meeting of Shareholders

TORONTO, June 15, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, is pleased to announce that shareholders overwhelmingly approved all proposed resolutions at its annual general and special meeting of shareholders (“... Read More...
Entourage Health Extends its Senior Secured Credit Facility Maturity Date

Entourage Health Extends its Senior Secured Credit Facility Maturity Date

TORONTO, June 01, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products confirmed today it has signed an additional amendment to its senior secured credit facility entered into on March 29, 2019 (the “Credit Facility”). The... Read More...
Entourage Health Reports Record First Quarter 2022 Financial Results

Entourage Health Reports Record First Quarter 2022 Financial Results

Gross revenue* of $17.4 million, up 28% sequentially and 37% year over year Total revenue of $15.8 million in Q1, 2022 represents a 17% sequential increase over Q4 2021Gross Profit Before Fair Value Changes improved $5.5 million sequentially Adjusted EBITDA improved $1.0 million from Q4 2021, reflecting higher gross profit as Company real... Read More...
Entourage Health Announces Canadian Debut of The Boston Beer Company's New Cannabis-Infused Iced Tea Beverages ‘TeaPot'

Entourage Health Announces Canadian Debut of The Boston Beer Company’s New Cannabis-Infused Iced Tea Beverages ‘TeaPot’

TORONTO, May 24, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and The Boston Beer Company, Inc. (NYSE: SAM), (“BBC”) maker of iconic, high-quality brands such as Samuel Adams, Truly Hard Seltzer and Twisted Tea, ar... Read More...
Entourage Health Reaffirms First Quarter 2022 Preliminary Record Revenues of $17.4 Million and Announces Financial Results Call to be held on May 31, 2022

Entourage Health Reaffirms First Quarter 2022 Preliminary Record Revenues of $17.4 Million and Announces Financial Results Call to be held on May 31, 2022

TORONTO, May 20, 2022 -- Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products announced today that it is scheduled to file its first quarter 2022 financial statements and management’s discussion and analysis after-market on Monday... Read More...
Entourage Health Enters into Voting Support Agreement and Announces Proposed Amendments to its 8.5% Unsecured Convertible Debentures

Entourage Health Enters into Voting Support Agreement and Announces Proposed Amendments to its 8.5% Unsecured Convertible Debentures

TORONTO, May 13, 2022 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, is pleased to announce that it has entered into voting support agreements with certain holders of the Company’s 8.5% unsecured c... Read More...
Entourage Health to Present at the Canaccord Genuity 6th Annual Global Cannabis Virtual Conference on May 11th

Entourage Health to Present at the Canaccord Genuity 6th Annual Global Cannabis Virtual Conference on May 11th

TORONTO, May 10, 2022 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, announced today that George Scorsis, CEO and Executive Chair, and Vaani Maharaj, Chief Financial Officer, are scheduled to prese... Read More...
Entourage Reports Record Fiscal Year 2021 Financial Results with $55.2 Million in Total Revenue for a 56% Year-Over-Year Increase and Preliminary Q1 2022 Record Revenue of $17.4 Million

Entourage Reports Record Fiscal Year 2021 Financial Results with $55.2 Million in Total Revenue for a 56% Year-Over-Year Increase and Preliminary Q1 2022 Record Revenue of $17.4 Million

Net revenue increased to $42.2 million for the full year ended December 31, 2021 Preliminary unaudited Q1 2022 total revenue $17.4 million(1) representing 35% YOY growthUpsized credit facility with LiUNA Pension Fund further improves liquidity position TORONTO, May 09, 2022 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OT... Read More...
Entourage Health Partners with Pineapple Express to Provide Same-Day Medical Cannabis Delivery Service to its Starseed Medicinal Patients

Entourage Health Partners with Pineapple Express to Provide Same-Day Medical Cannabis Delivery Service to its Starseed Medicinal Patients

TORONTO, May 04, 2022 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, announced today it has entered into an agreement with Fire & Flower Holdings Corp. ("Fire & Flower") (TSX: FAF; OTCQX: F... Read More...
Entourage Health Reschedules Full-Year 2021 Earnings Release and Conference Call to Align with First Quarter 2022 Results

Entourage Health Reschedules Full-Year 2021 Earnings Release and Conference Call to Align with First Quarter 2022 Results

Company reaffirms previously announced full-year 2021 preliminary revenue with further improvements at $55.2 million(1) and preliminary gross margins of 7.0%(1) for the year TORONTO, May 03, 2022 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and di... Read More...
Entourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $15 Million in Funding Availability

Entourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $15 Million in Funding Availability

TORONTO, April 29, 2022 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and brands, is pleased to announce it has amended and upsized its existing credit facility (the “Credit Facility”) with an affi... Read More...
Entourage Updates Timing of Fiscal Year 2021 Financial Results Call to May 3, 2022

Entourage Updates Timing of Fiscal Year 2021 Financial Results Call to May 3, 2022

Company reaffirms preliminary fiscal year 2021 record revenue of $54.8 million(1)Results to be filed after-market May 2, 2022, with management hosting a call on following day TORONTO, April 22, 2022 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and... Read More...
Entourage Health Extends Senior Secured Credit Facility Maturity Date

Entourage Health Extends Senior Secured Credit Facility Maturity Date

TORONTO, March 30, 2022 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products confirmed today it has signed an additional amendment (the “Amendment”) to its senior secured credit facility entered into on M... Read More...
Entourage Health Launches ‘Joints for Justice' Retail Campaign to Raise Funds and Awareness in Support of Cannabis Amnesty

Entourage Health Launches ‘Joints for Justice’ Retail Campaign to Raise Funds and Awareness in Support of Cannabis Amnesty

TORONTO, March 25, 2022 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and brands, announced today that its Royal City Cannabis Co. (“Royal City") brand recently launched ‘RC Joints for Justice’, a ... Read More...
Entourage Health Appoints Finance Executive Vaani Maharaj as New Chief Financial Officer and Updates Timing of Q4 and Full-Year 2021 Financials to April 26

Entourage Health Appoints Finance Executive Vaani Maharaj as New Chief Financial Officer and Updates Timing of Q4 and Full-Year 2021 Financials to April 26

Ms. Maharaj to succeed Beth Carreon who is stepping down from CFO role effective May 4, 2022Company also reaffirms preliminary fiscal year 2021 record revenue of $54.8 million(1)Management to host financial results conference call on April 26, 2022 at 10 a.m. Eastern time TORONTO, March 24, 2022 -- Entourage Health Corp. (formerly WeedMD ... Read More...
Entourage Health Debuts New 2022 Color Cannabis Branding Campaign and Celebrates All-Female-Led Marketing and Promotions Team

Entourage Health Debuts New 2022 Color Cannabis Branding Campaign and Celebrates All-Female-Led Marketing and Promotions Team

TORONTO, March 08, 2022 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and brands is pleased to unveil the refresh of its Color Cannabis (“Color”) adult-use brand with the launch of its new 2022 bra... Read More...
Entourage Health Announces Preliminary Fiscal Year 2021 Record Revenue of $54.8 Million with Q4 and Full-Year 2021 Financials to be filed by April 1, 2022  

Entourage Health Announces Preliminary Fiscal Year 2021 Record Revenue of $54.8 Million with Q4 and Full-Year 2021 Financials to be filed by April 1, 2022  

FYE 2021 revenues up 54% over prior year due to record sales and expanded market share(1)Conference call to review financial results to be held on April 1, 2022 at 10 a.m. Eastern time Company also provides a corporate update to confirm George Scorsis as permanent CEO TORONTO, Feb. 11, 2022 -- Entourage Health Corp. (formerly WeedMD Inc.)... Read More...
Entourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $20 Million in Non-Dilutive Financing

Entourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $20 Million in Non-Dilutive Financing

TORONTO, Dec. 24, 2021 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and brands, announced today it has amended its existing credit facility (“Credit Facility”) with an affiliate of the LiUNA Pensi... Read More...
Entourage Health Enhances Cultivation Platform with Tissue Culture IP and Introduces New Genetics for Premium Adult-Use and Medical Product Lineup in 2022

Entourage Health Enhances Cultivation Platform with Tissue Culture IP and Introduces New Genetics for Premium Adult-Use and Medical Product Lineup in 2022

TORONTO, Dec. 15, 2021 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and brands, announced today it has upgraded its cultivation platform to include a unique Company-wide standardized system rooted... Read More...
Entourage Health Launches Cannabis-Infused Soft Chews for Starseed Medicinal Line

Entourage Health Launches Cannabis-Infused Soft Chews for Starseed Medicinal Line

TORONTO, Nov. 29, 2021 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and brands, is pleased to announce it has entered into a commercial arrangement with Olli Brands Inc. ("OBi”) to produce a suite... Read More...
Entourage Health Reports Q3 Financial Results with $14.9 Million Record Revenue Representing 94% YOY Increase and Fourth Consecutive Quarter of Growth

Entourage Health Reports Q3 Financial Results with $14.9 Million Record Revenue Representing 94% YOY Increase and Fourth Consecutive Quarter of Growth

Adult-Use net revenue for the quarter increased by 102% compared to last yearSales, general and administrative costs decreased by 16% compared to last yearStrategic acquisition of craft cultivator CannTx will introduce new genetics, IP and cultivars Management to host conference call today at 10:00 a.m. Eastern Time TORONTO, Nov. 16, 2021... Read More...
Entourage Health Closes Acquisition of Craft Cultivator CannTx Life Sciences Inc.

Entourage Health Closes Acquisition of Craft Cultivator CannTx Life Sciences Inc.

Closing of deal merges craft brand Royal City Cannabis Co. into Entourage’s product portfolio Company enhances board with two new appointments from CannTx Life SciencesEntourage also completes amendments to its second secured $30 million credit facility TORONTO, Nov. 01, 2021 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (... Read More...
Entourage Health Announces Preliminary Q3 Record Revenue of $14.7 Million and Confirms Financial Results Call to be Held on November 16, 2021 at 10 a.m. ET

Entourage Health Announces Preliminary Q3 Record Revenue of $14.7 Million and Confirms Financial Results Call to be Held on November 16, 2021 at 10 a.m. ET

Fourth consecutive quarter of growth attributed to expanding market share and record salesCompany also completes amendments to its $39 million senior secured credit facility TORONTO, Oct. 19, 2021 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and ... Read More...
Entourage Health Announces Filing of Amended Financial Statements and MD&A

Entourage Health Announces Filing of Amended Financial Statements and MD&A

TORONTO, Oct. 15, 2021 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and brands, today announces that, as a result of a continuous disclosure review conducted by staff of the Ontario Securities Com... Read More...
Entourage Health Launches Mary's Medicinals Transdermal Cannabis Patches in Canada

Entourage Health Launches Mary’s Medicinals Transdermal Cannabis Patches in Canada

Innovative suite of Mary’s line-up produced locally now includes Transdermal Patches in CBD, THC and 1:1 formulations that offer a novel, alternative path to cannabinoid deliveryWith over 40 medical product SKUs available to patients across Canada, as of late September 2021, Starseed Medicinal clients will have exclusive access to Mary’s ... Read More...
Entourage Health Launches Fire & Flower-branded CBD Softgel Product Line

Entourage Health Launches Fire & Flower-branded CBD Softgel Product Line

TORONTO, Sept. 09, 2021 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and brands, in collaboration with leading Canadian retailer Fire & Flower Inc. (“Fire & Flower”) (TSX:FAF; OTCQX:FFLWF)... Read More...
Entourage Health Announces New Ticker Symbol on U.S.-Based OTCQX Market as ‘ETRGF' Effective September 1, 2021

Entourage Health Announces New Ticker Symbol on U.S.-Based OTCQX Market as ‘ETRGF’ Effective September 1, 2021

TORONTO, Sept. 01, 2021 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX: ETRGF), (formerly OTCQX: WDDMF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products and brands, announced that effective at market open on September 1, 2021, the OTCQX market ticker sym... Read More...
Entourage Health Partners with Boston Beer Subsidiary to Launch and Sell Portfolio of Innovative Cannabis-Infused Beverages in Canada

Entourage Health Partners with Boston Beer Subsidiary to Launch and Sell Portfolio of Innovative Cannabis-Infused Beverages in Canada

Entourage holds exclusive rights to sell, market and distribute Boston Beer-branded and licensed non-alcoholic cannabis beverages produced by Althea’s subsidiary Peak ProcessingCompany also enters into supply agreement with Peak to provide cannabinoid-rich input biomass to Peak to formulate and manufacture the cannabis beverage products i... Read More...
Entourage Health Reports Q2 Financial Results with $13.8 Million Record Revenue Representing 92% YOY Increase and Third Consecutive Quarter of Growth

Entourage Health Reports Q2 Financial Results with $13.8 Million Record Revenue Representing 92% YOY Increase and Third Consecutive Quarter of Growth

Continued record sales of higher-margin products in all channels drives 29% gross marginFulfilled record purchase orders from every province, focusing on top-performing products resulting in a 159% increase in adult-use sales YOY and a 55% increase in Q2 market shareManagement to host conference call today at 10:00 a.m. Eastern Time TORON... Read More...
Entourage Health Announces Preliminary Record Q2 Revenues of $13.6 Million and Confirms Financial Results Call to be Held on August 10, 2021 at 10 a.m. ET

Entourage Health Announces Preliminary Record Q2 Revenues of $13.6 Million and Confirms Financial Results Call to be Held on August 10, 2021 at 10 a.m. ET

TORONTO, July 20, 2021 -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:WDDMF) (FSE:4WE) (“Entourage” or the “Company”), is pleased to announce preliminary unaudited revenues of $13.6 million(1) for the three months ended June 30, 2021, representing another sequential quarter of record sales growth across its adult-use... Read More...
WeedMD Inc. and CannTx Life Sciences Sign Definitive Acquisition Agreement and Confirm Corporate Name as Entourage Health Corp.

WeedMD Inc. and CannTx Life Sciences Sign Definitive Acquisition Agreement and Confirm Corporate Name as Entourage Health Corp.

On closing, merged company to combine innovative medical business, low-cost cultivation, specialized craft cannabis, micropropagation, and solventless extraction capabilitiesTop-selling, award-winning brands include Color Cannabis, Saturday Cannabis, Royal City Cannabis Co., Starseed Medicinal, and U.S. licensed-brand Mary’s Medicinals St... Read More...
WeedMD Reports First Quarter 2021 Financial Results with 102% Record Increase in Sequential Net Revenue Growth

WeedMD Reports First Quarter 2021 Financial Results with 102% Record Increase in Sequential Net Revenue Growth

Total revenue (before excise duties) of $12.9 million in Q1 2021, represents over 7% favourability over the $12.0 million Q1 2021 guidance previously providedNet revenue of $10.3 million in Q1 2021, represents a 102% sequential increase over Q4 2020, reflecting record sales of higher-margin, direct-to-consumer, and direct-to-patient produ... Read More...
WeedMD Expands its Color Cannabis Brand into the Province of New Brunswick

WeedMD Expands its Color Cannabis Brand into the Province of New Brunswick

TORONTO, June 28, 2021 -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally licensed producer and distributor of medical-grade cannabis, is pleased to announce the expansion of its Color Cannabis brand into the Province of New Brunswick, following receipt of its first purchase order from Cannabis NB,... Read More...
Coming Soon.
IndexLast% Change
S&P 5003,693.23--
Euro STOXX 503,348.290.01%Negative
FTSE 1006,963.840.78%Negative
Nikkei 22526,431.552.66%Negative

Delayed data (1h)
IndexLast% Change
S&P 5003,693.23--
Euro STOXX 503,348.290.01%Negative
FTSE 1006,963.840.78%Negative
Nikkei 22526,431.552.66%Negative


Share this page